Frontiers in Immunology, 2024 · DOI: 10.3389/fimmu.2024.1368203 · Published: March 13, 2024
Spinal cord injury (SCI) leads to tissue cell debris at the injury site, interacting with cytokines and the central nervous system's glial environment to create an inhibitory microenvironment, hindering nerve regeneration. Macrophages, responsible for removing tissue debris after SCI, can transform into foamy macrophages due to high lipid content and dysregulated lipid metabolism, exacerbating inflammation and impeding nerve repair. This review summarizes macrophage phenotype and metabolism under inflammatory conditions, the mechanisms and consequences of foam cell formation after SCI, and discusses potential therapeutic targets for SCI treatment.
Modulating lipid uptake receptors such as CD36, CD204, and LOX-1 may reduce lipid accumulation in macrophages and subsequent foam cell formation.
Promoting the reverse cholesterol transport pathway by targeting ApoA-I, ApoE, ABCA1, and ABCG1 can help clear excess lipids from macrophages, preventing foam cell transformation.
Exogenous ApoE mimetic peptides show promise as neuroprotective agents capable of crossing the blood-brain barrier and inhibiting foam cell formation after spinal cord injury.